HAX
HAX is a venture capital program focused on accelerating hardware startups through its comprehensive support and resources. Founded in 2012 and headquartered in Newark, New Jersey, HAX operates in two key locations, San Francisco and Shenzhen, providing founders with an environment conducive to rapid prototyping and iterative development. The program emphasizes the importance of launching both B2C and B2B hardware startups, guiding them through critical phases such as business development, fundraising, and market entry. HAX accepts teams that demonstrate strong potential for scaling their ventures and solving significant technological challenges. Through a structured curriculum, entrepreneurs refine their product-market fit and business strategies while benefiting from a robust network of mentors and industry connections. HAX maintains an ongoing relationship with participating startups to support their growth beyond the initial program, ensuring they have the necessary resources and partnerships to succeed in the competitive marketplace.
Flow Neuroscience
Convertible Note in 2024
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.
Flow Neuroscience
Series A in 2021
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.
Neurode
Seed Round in 2021
Neurode is focused on the development of a non-invasive wearable headset aimed at enhancing cognitive performance for individuals with neurological conditions, particularly ADHD. This innovative device employs electrical stimulation to address the imbalances in brain activity commonly associated with ADHD. Alongside the headset, Neurode offers a companion application that monitors users' progress and shares improvements with healthcare professionals. This drug-free approach seeks to alleviate symptoms such as working memory deficits, attention challenges, and impulse control issues, ultimately enabling better management of cognitive performance for users.
Flow Neuroscience
Convertible Note in 2020
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.
Mindset Innovation, Inc., based in Montreal, Canada, designs and manufactures headphones aimed at enhancing employee concentration. The company's flagship product line includes enophones, enosound, and enowork, which utilize advanced technology such as electroencephalograms to monitor brainwaves in real-time. These headphones not only track mental fitness but also alert users when their concentration levels drop, promoting improved focus and the development of positive work habits. By enabling users to understand and manage their attention more effectively, the eno platform seeks to unlock individual potential and foster a more productive work environment. Founded in 2016, Mindset Innovation offers its products through online channels, emphasizing user engagement and self-improvement in workplace settings.
Flow Neuroscience
Seed Round in 2018
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.
Mindset Innovation, Inc., based in Montreal, Canada, designs and manufactures headphones aimed at enhancing employee concentration. The company's flagship product line includes enophones, enosound, and enowork, which utilize advanced technology such as electroencephalograms to monitor brainwaves in real-time. These headphones not only track mental fitness but also alert users when their concentration levels drop, promoting improved focus and the development of positive work habits. By enabling users to understand and manage their attention more effectively, the eno platform seeks to unlock individual potential and foster a more productive work environment. Founded in 2016, Mindset Innovation offers its products through online channels, emphasizing user engagement and self-improvement in workplace settings.
Kokoon Technology Limited, established in 2013 and headquartered in London, specializes in sleep technology. The company manufactures headphones equipped with EEG brainwave sensing technology and movement sensors, enabling precise sleep monitoring. Kokoon's products include active noise cancellation, noise isolation, and active white noise features, along with a mobile app offering a relaxation audio library and personalized sleep analysis. The company aims to make sleep science more accessible and enjoyable, delivering personalized audio coaching and experiences through its app-based software platform.
ThinkMelon
Pre Seed Round in 2012
ThinkMelon is a Santa Monica-based developer of a brainwave and biofeedback device that focuses on enhancing users' mental focus. The company offers a sensor-enabled headband that measures brain activity through electroencephalography and pairs it with a mobile application. This system interprets brainwave data to provide users with valuable feedback, tips, and insights aimed at improving focus and mindfulness. By making brain activity visible, ThinkMelon helps individuals work more efficiently, study smarter, and achieve a clearer state of mind. The combination of hardware and a user-friendly app is rooted in scientific principles, providing users with a unique experience to better understand themselves and enhance their everyday performance.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.